All-cause and cause-specific mortality assessment in patients receiving sodium glucose co-transporter-2 inhibitors: A meta-analysis of randomized controlled trials

By afschroeder • March 29, 2026

Jaiswal V, Mashkoor Y, Waqas M, Khan MS, Ahmed A, Deb N, Banach M, Dani SS, Zelniker TA, Alexander KM, Fonarow GC, Qamar A. All-cause and cause-specific mortality assessment in patients receiving sodium glucose co-transporter-2 inhibitors: A meta-analysis of randomized controlled trials. Am J Med. 2026 Mar 26:S0002-9343(26)00227-5. doi: 10.1016/j.amjmed.2026.03.024. Epub ahead of print. PMID: 41903643.

Tags: Cardiology/Epi, cardiovascular mortality, Chronic kidney disease, diabetes, heart failure, mortality, outcome analysis, Publications, SGLT2I

Fatty Acid and Oxylipin Metabolism Differentiate Isolated Postcapillary From Combined Pre- and Postcapillary Pulmonary Hypertension

Alotaibi M, Tang A, Sun N, Gurholt I, Yuguchi E, Roberts K, Preston I, Warburton R, Yuan JX, Kim NH, Chan SY, Jain M, Cheng[...]

Artificial intelligence-enabled electrocardiography for detection of left ventricular diastolic dysfunction: a systematic review and meta-analysis

Edjimbi J, Shah N, Donisi L, Gajjar A, See C, Grimshaw AA, Diop HB, Ribeiro ALP, Marijon E, Clifford G, Gaye B. Artificial intelligence-enabled electrocardiography[...]

Heart failure among people with HIV: prescription of guideline-directed medical therapy

Cutshaw MK, Clare R, Chiswell K, Hofmann P, Pettit AC, Meissner E, Durstenfeld MS, Longenecker CT, Bloomfield GS, Okeke NL. Heart failure among people with[...]